![Vascular Tumors]( https://vascern.eu/app/themes/trinity/public/images/loading.gif?id=d41d8cd98f00b204e980 )
With vaccination programs against SARS-CoV-2 already underway across Europe, VASCERN’s Rare Disease Working Groups have produced individual statements for their patients when it comes to COVID-19 vaccinations. The following statements are now available:
Hereditary Haemorrhagic Telangiectasia (HHT)
Heritable Thoracic Aortic Diseases (HTAD)
Medium-Sized Arteries (MSA) Working Group – vascular Ehlers-Danlos syndrome (vEDS)
Pediatric and Primary Lymphedema (PPL)
As a reminder, you can find all of VASCERN’s COVID-19 recommendations by clicking the button on the homepage here.
![](/app/uploads/2023/03/COVID.png)
For more info on the European Commission’s Common European coronavirus response, please click here
For a list of COVID-19 resources and recommendations (including those of VASCERN and the other ERNs) collected by Eurordis click here, and by Orphanet click here.